Sales & Marketing

Jan 28, 2016
Companies must design local commercial models that enable them to deliver value stories tailored to the specific needs of organized customers and the characteristics of local ecosystems, writes Paul Darling.
Jan 15, 2016
In the consumer’s eye, the one thing worse than annoying internet ads is the widely held belief that too much personal information is held online when it comes to online marketing. Graeme Hutton reports.
Jan 15, 2016
Pharmaceutical Executive
Al Topin lists the “seven significants” for brand planning in 2016 that pose the best chance for stable footing amid the seismic state of today’s ever-changing healthcare landscape.
Jan 05, 2016
The traditional commercial sales model in biopharma of deploying teams of reps to call on physicians is broken. Here, Todd Greenwood outlines a new approach.
Jan 04, 2016
Defending pharma and health director-to-consumer advertising is a top 2016 priority for the 4A’s industry trade group. Mollie Rosen reports.
Dec 20, 2015
Pharmaceutical Executive
The eight trends brought on by “once-and-done” interventions that may transform thinking around healthcare marketing.
Dec 11, 2015
Three days at TEDMED has convinced Bill Drummy that a dramatic shift in your definition of what’s possible is not only re-energizing, it can also help you approach your biggest problems in ways you would have never otherwise considered.
Dec 01, 2015
Physicians who show true empathy for their patients tend to have better outcomes. Their patients stick to treatment plans, heal faster, and have fewer hospital readmissions. The same principle applies to pharma companies trying to market to physicians, write Pratap Khedkar and Malcolm Sturgis.
Nov 30, 2015
Healthcare agencies are being given a place at the table at ad industry’s top award shows. And while not close enough to rub elbows with the Don Drapers and Peggy Olsons of the ad world, at least they’re being invited, writes Marylyn Donahue.
Nov 09, 2015
After months of anticipation, pharma marketers continue to wait for FDA to update its policies governing sponsor communications involving unapproved drug uses.
lorem ipsum